Translational and Health Informatics : Implications for Drug Discovery
The European Quantitative Structure-Activity Relationships (EuroQSAR) Symposia are major scientific events that have been organized in different cities of Europe since 1973. They have the fascinating scope to promote and disseminate advances in rational approaches in drug design and discovery and ensure a worldwide attendance of prominent scientists from both academia and industry.
The 22nd EuroQSAR 2018 symposium, entitled “Translational and Health Informatics: Implications for Drug Discovery”, will take place September 16-20, 2018 in Thessaloniki, Greece. It is a Turkish-Greek co-organization and an EFMC sponsored event.
To honor his impact of his contributions in the field of computer-aided drug discovery (CADD) and QSAR, the 22 nd EuroQSAR Symposium is dedicated to the memory of Prof. Toshio Fujita (1929-2017).